Background: When encountering a pelvic mass, CA 125 and CEA are usually obtained to evaluate for ovarian or colon cancer. The clinical importance of ordering a CA 19-9 level is unknown. Does it offer valuable information or merely add confusion and additional workup if elevated? Methods: 3,370 women were retrospectively identified via CPT codes for pelvic mass and CA 19-9. Initial analysis reviewed the subspecialty of the primary investigator using CA 19-9 in their initial workup, and its correlation to a gynecologic pathology. In the cases where an OBGYN was the primary investigator additional tumor markers, age, race, menopausal status, imaging, surgical interventions and final pathology were further analyzed. Results: Out of 3,370 women ...
Introduction Management of a woman with a pelvic mass is complicated by difficulty in discriminating...
CA 125 is the most reliable serum marker for ovarian carcinoma. Whereas its role in the screening of...
Serum CA 125 and CA 19-9 were presurgically measured in 40 patients with ovarian carcinoma and in 10...
BackgroundCA 125 is a tumour marker; commonly, used for screening ovarian malignancy. However, recen...
To test the value of serum CA-125 measurements alone or as part of a multimodal strategy to distingu...
Purpose To test the value of serum CA-125 measurements alone or as part of a multimodal strategy to ...
To evaluate the diagnostic and prognostic value of serum CA19-9, CA125 and CP2 in mucinous ovarian t...
To prospectively evaluate the results of the CA-125 analyses performed on the IOTA (International Ov...
Objectives. The goals of this study were to analyze preoperative serum levels of CA 125, carcinoembr...
Objective: To evaluate thè efficacy of five methods: pelvic examination (PE), transvaginal ultrasono...
CONTEXT: There is no adequate preoperative method for differentiating between benign and malignant p...
The serum levels of CA 125 (cutoff limit, 65 U/ml), CA19.9 (cutoff, 40 U/ml), CA 15.3 (cutoff, 32 U/...
Objective: We sought to determine the validity of cancer antigen 125 (CA-125) and the risk of malign...
OBJECTIVES: To determine whether CA 125 measurement is superior to ultrasound imaging performed ...
Previous reports have shown that some ovarian endometrioid adenocarcinomas and ovarian clear cell ad...
Introduction Management of a woman with a pelvic mass is complicated by difficulty in discriminating...
CA 125 is the most reliable serum marker for ovarian carcinoma. Whereas its role in the screening of...
Serum CA 125 and CA 19-9 were presurgically measured in 40 patients with ovarian carcinoma and in 10...
BackgroundCA 125 is a tumour marker; commonly, used for screening ovarian malignancy. However, recen...
To test the value of serum CA-125 measurements alone or as part of a multimodal strategy to distingu...
Purpose To test the value of serum CA-125 measurements alone or as part of a multimodal strategy to ...
To evaluate the diagnostic and prognostic value of serum CA19-9, CA125 and CP2 in mucinous ovarian t...
To prospectively evaluate the results of the CA-125 analyses performed on the IOTA (International Ov...
Objectives. The goals of this study were to analyze preoperative serum levels of CA 125, carcinoembr...
Objective: To evaluate thè efficacy of five methods: pelvic examination (PE), transvaginal ultrasono...
CONTEXT: There is no adequate preoperative method for differentiating between benign and malignant p...
The serum levels of CA 125 (cutoff limit, 65 U/ml), CA19.9 (cutoff, 40 U/ml), CA 15.3 (cutoff, 32 U/...
Objective: We sought to determine the validity of cancer antigen 125 (CA-125) and the risk of malign...
OBJECTIVES: To determine whether CA 125 measurement is superior to ultrasound imaging performed ...
Previous reports have shown that some ovarian endometrioid adenocarcinomas and ovarian clear cell ad...
Introduction Management of a woman with a pelvic mass is complicated by difficulty in discriminating...
CA 125 is the most reliable serum marker for ovarian carcinoma. Whereas its role in the screening of...
Serum CA 125 and CA 19-9 were presurgically measured in 40 patients with ovarian carcinoma and in 10...